Bacterial cell wall components as immunomodulators--I. Lipopeptides as adjuvants for parenteral and oral immunization. 1997

W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
Institut für Immunbiologie der Universität Freiburg, Germany.

We investigated the immunostimulatory properties of synthetically prepared lipopeptides derived from the cell wall of Gram negative bacteria. These compounds constitute potent macrophage activators and polyclonal B-lymphocyte stimulators. They are also immunoadjuvants in parenteral or oral immunization. By coupling the lipopeptides to haptens or low molecular weight antigens which are not immunogenic per se, highly immunogenic conjugates can be prepared. Lipopeptide antigen conjugates as synthetic vaccines give protection by enhancing the antibody-mediated immune response, and they stimulate the cellular immune response in vivo by priming of cytotoxic T-cells.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D005536 Foot-and-Mouth Disease A highly infectious disease caused by FOOT AND MOUTH DISEASE VIRUS that affects mammals of the ARTIODACTYLA order (CATTLE; SHEEP; GOATS; and PIGS) and is characterized by high fever followed by the appearance of blisters inside the mouth and on the feet. Foot and Mouth Disease,Disease, Foot-and-Mouth,Diseases, Foot-and-Mouth,Foot-and-Mouth Diseases
D005620 Freund's Adjuvant An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity (IMMUNITY, CELLULAR) and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria. Freund Adjuvant,Adjuvant, Freund,Adjuvant, Freund's,Freunds Adjuvant
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006377 T-Lymphocytes, Helper-Inducer Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions. Helper Cell,Helper Cells,Helper T Cell,Helper-Inducer T-Lymphocytes,Inducer Cell,Inducer Cells,T-Cells, Helper-Inducer,T-Lymphocytes, Helper,T-Lymphocytes, Inducer,Helper T-Cells,Cell, Helper T,Cells, Helper T,Helper Inducer T Lymphocytes,Helper T Cells,Helper T-Cell,Helper T-Lymphocyte,Helper T-Lymphocytes,Helper-Inducer T-Cell,Helper-Inducer T-Cells,Helper-Inducer T-Lymphocyte,Inducer T-Lymphocyte,Inducer T-Lymphocytes,T Cell, Helper,T Cells, Helper,T Cells, Helper Inducer,T Lymphocytes, Helper,T Lymphocytes, Helper Inducer,T Lymphocytes, Inducer,T-Cell, Helper,T-Cell, Helper-Inducer,T-Cells, Helper,T-Lymphocyte, Helper,T-Lymphocyte, Helper-Inducer,T-Lymphocyte, Inducer
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
January 1990, Lung,
W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
January 1997, International journal of immunopharmacology,
W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
July 1994, Clinical microbiology reviews,
W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
June 1992, Research in immunology,
W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
December 2010, Annals of the New York Academy of Sciences,
W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
June 1992, Research in immunology,
W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
June 1989, Vaccine,
W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
January 1996, ALTEX,
W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
January 1993, Die Naturwissenschaften,
W G Bessler, and L Heinevetter, and K H Wiesmüller, and G Jung, and W Baier, and M Huber, and A R Lorenz, and U V Esche, and K Mittenbühler, and P Hoffmann
March 1999, Infection and immunity,
Copied contents to your clipboard!